Vanguard Fiduciary Trust
ANIX icon

Vanguard Fiduciary Trust’s Anixa Biosciences ANIX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$539K Buy
192,356
+1,282
+0.7% +$3.56K ﹤0.01% 3245
2026
Q1 		$493K Buy
+191,074
New +$566K ﹤0.01% 3215

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Vanguard Fiduciary Trust's ANIX Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Anixa Biosciences (ANIX) stake by 0.67% in Q2 2026, buying an estimated $3.56K and bringing the position to 192,356 shares worth $539K. The position accounts for ﹤0.01% of the portfolio, ranked #3245.

Vanguard Fiduciary Trust first reported a position in ANIX in Q1 2026 and has held it in 2 quarters since. 63 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • Vanguard Fiduciary Trust held 192,356 shares of Anixa Biosciences worth $539K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 1,282 Anixa Biosciences shares in Q2 2026, an estimated $3.56K.
  • Anixa Biosciences made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3245 holding.
  • Vanguard Fiduciary Trust first reported a position in Anixa Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 63 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.